NCT07193017
The Effect of BIPAP on Diaphragmatic Function
StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 19 words Show 5 more changesShow less
- Primary endpoints: details revised at 1 of 11 entries
- Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Primary completion pushed from Oct 15, 2026 to Mar 15, 2027
- Secondary endpoints: details revised at 1 of 2 entries
- Site contact updated
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
One-Year Survival
Timeframe: at baseline and after 12 months
Number of Hospital Admissions within 12 Months
Timeframe: at baseline and after 12 months
Maximum Inspiratory Pressure (MIP)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year
Maximum Expiratory Pressure (MEP)
Timeframe: At baseline, after 6 weeks of BiPAP usage, and after one year.
Forced Vital Capacity (FVC)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Forced Expiratory Volume in 1 Second (FEV₁)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
FEV₁/FVC Ratio
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Cough Strength (Peak Cough Flow, PCF)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Diaphragm Thickness (B-mode Ultrasound)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Diaphragm Excursion (M-mode Ultrasound)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Diaphragmatic Tissue Velocity (Tissue Doppler Imaging)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Secondary (2)
COPD Assessment Test (CAT) Score:
Dyspnea (mMRC Scale)
Arms and interventions
copd patients
Patients diagnosed with chronic obstructive pulmonary disease (COPD) who have been prescribed BiPAP therapy by a physician. Participants will undergo diaphragmatic function evaluations with ultrasound at baseline, after 6 weeks of BiPAP usage, and after one year.
Devices: BIPAP
Sites
1 site in 1 country
- Demiroglu Bilim University, Department of Physiotherapy and RehabilitationIstanbul, Turkey (Türkiye)